Suggested Ontology for Pharmacogenomics
Ontology: SOPHARM
- IRI: http://purl.obolibrary.org/obo/sopharm.owl
- OBO Foundry: Library
- Home: http://www.loria.fr/~coulet/sopharm2.0_description.php
- Documentation: SO-Pharm documentation
- Contact: Adrien Coulet
- Description: SO-Pharm is a formal ontology that represent domain knowledge in pharmacogenomics. To achieve this goal SO-Pharm articulates ontologies from sub domains of phamacogenomics (i.e. genotype, phenotype, drug, trial representations). SO-Pharm enables to support knowledge about pharmacogenomic hypothesis, case study, and investigations in pharmacogenomics.
Number of Terms (including imported terms) (Detailed Statistics)
Top level terms and selected core terms
- 17-yohimbol
- alpha-aminoacyl-tRNA
- amino-acid residues
- AminoAcid
- ammonium ions
- application ontology
- arsonic acid derivatives
- atoms
- biological role ontology
- canonical nucleoside residues
- clinical item
- cystein-S-yl group
- cysteino group
- database
- dehydroascorbate
- Disease Ontology V2.1 2005
- drug
- elementary particles
- entity
- family_member
- genomic_region
- genotype
- glutathione derivatives
- groups
- label
- limonene 1,2-epoxide
- methyl myo-inositols
- N(pros)-histidino group
- N(tele)-histidino group
- nuclei
- nucleon
- nutrient
- observed_variation
- organosulfonates
- OWLList
- oxoacid derivatives
- protein_region
- quality
- sequence_attribute
- sequence_collection
- sequence_feature
- sequence_variant
- silyl groups
- to_be_fixed
- transcript change
- transcript_region
- translational product change
- unit
- ValuePartition
- variant
- _deleted_classes
Number of SPARQL queries:8
